AMADEUS4-1: Sarcopenia study

A multi-institutional study on the assessment of sarcopenia and its relationship to ability in pediatric and AYA cancer survivors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030220014

Enrollment

Registered

2022-04-08

Start date

2022-04-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All cancer patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) All cancer patients scheduled for initial treatment at the study site. 2) Patients aged between 16 and 39 years at the time of consent. 3) Written consent has been obtained from the individual (if the research subject is a minor 16 years of age or older, written consent should be obtained from a surrogate in addition to the individual).

Exclusion criteria

Exclusion criteria: 1) Patients who cannot be assessed for their ambulance status due to poor general condition. 2) Patients deemed inappropriate by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Incidence of sarcopenia	—

Secondary

Measure	Time frame
ADL assessment	—

Contacts

Public ContactShintaro Iwata

National Cancer Center Hospital

shiwata@ncc.go.jp+81-3-3542-2511

Outcome results